Q2 FY2026 · ended Jun 30, 2026 · Revenue $45.38M, -4.2% YoY · Filed Aug 7, 2026
Treace Medical Concepts, Inc. (TMCI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $45.4 million and a net loss of $15.9 million. Free cash flow was -$6.9 million. As of Jun 30, 2026 it held $45.6 million in cash and investments and $72.7 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TMCI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- Accelerated filer
- SEC CIK
- 1630627
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $45.4M | $47.2M | $62.5M | $50.2M | $47.4M |
| Operating income | -$15.0M | -$17.2M | -$5.9M | -$15.7M | -$17.0M |
| Net income | -$15.9M | -$18.0M | -$9.4M | -$16.3M | -$17.4M |
| Diluted EPS | -$0.24 | -$0.28 | -$0.15 | -$0.26 | -$0.28 |
| Operating cash flow | -$4.7M | $7.2M | -$8.0M | -$9.1M | -$3.0M |
| Free cash flow | -$6.9M | $4.2M | -$10.4M | -$11.9M | -$7.8M |
| Total assets | $181.1M | $184.1M | $190.6M | $196.6M | $206.4M |
| Total liabilities | $113.3M | $106.9M | $103.2M | $107.4M | $108.8M |
| Stockholders' equity | $67.7M | $77.2M | $87.3M | $89.2M | $97.6M |
| Cash and investments | $45.6M | $51.9M | $48.4M | $57.4M | $69.3M |
| Total debt | $72.7M | $71.6M | $71.9M | $70.4M | $70.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2026 | Nov 6, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 19, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
All 445 Treace Medical Concepts, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.